However, overall psoriasis-associated genes and genes belonging to signaling pathways of IL-22, IFNγ, TNFα, IL-1, and IL-17 were more strongly suppressed by ustekinumab than by etanercept. The gene discussed is IL22; the disease is psoriasis.